- Home
- FUTU vs ELAN Comparison
FUTU vs ELAN Comparison
Compare FUTU & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FUTU | ELAN |
|---|---|---|
| Founded | 2011 | 1954 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 12.7B |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FUTU | ELAN |
|---|---|---|
| Price | $96.11 | $24.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $217.75 | $27.89 |
| AVG Volume (30 Days) | 5.5M | ★ 6.9M |
| Earning Date | 05-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | $27.96 | $8.21 |
| Revenue Next Year | $11.89 | $5.31 |
| P/E Ratio | ★ $17.05 | $215.05 |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $80.50 | $13.16 |
| 52 Week High | $202.53 | $27.72 |
Technical Indicators
Market Signals| Indicator | FUTU | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 29.88 | 60.90 |
| Support Level | $80.50 | $23.72 |
| Resistance Level | $172.56 | $25.78 |
| Average True Range (ATR) | 7.36 | 1.00 |
| MACD | -2.29 | 0.36 |
| Stochastic Oscillator | 23.73 | 98.02 |
Price Performance
Historical ComparisonAbout FUTU Futu Holdings Limited
Futu Holdings Ltd is an online broker providing one-stop online investing services.. Through its proprietary digital platforms, Futubull and Moomoo, the Company provides a full range of investment services, including trade execution and clearing, margin financing and securities lending, and wealth management. The Group engages in online brokerage services and margin financing services. It generates its revenue in the form of brokerage commission and handling charge services, and interest income. Geographically, it operates in Hong Kong, which derives key revenue and it also has its presence in other countries.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.